December 21, 2021 10:12 AM ESTUpdated 10:24 AM

With few treatment options for Omicron, convalescent plasma is ready for a comeback — will the FDA be on board with outpatient use?

New research from Johns Hopkins shows convalescent plasma may work in the outpatient space, which could be key as the Omicron variant has

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

With few treat­ment op­tions for Omi­cron, con­va­les­cent plas­ma is ready for a come­back — will the FDA be on board with out­pa­tient use?